Clinical Verification of ACTT Assay, a Modification of the Hemochron Jr. ACT + Assay With Increased Specificity For the Direct Thrombin Inhibitor Bivalirudin (Angiomax)

Grants and Contracts Details

StatusFinished
Effective start/end date10/6/0310/6/03